Sfmbt2 - Scm-like with four mbt domains 2

Predicted to enable chromatin binding activity and histone binding activity. Predicted to be involved in negative regulation of gene expression and negative regulation of transcription, DNA-templated. Predicted to be located in aggresome; cytosol; and nuclear speck. Predicted to be active in nucleus. Is expressed in several structures, including extraembryonic component; liver; lung; placenta; and spleen. Orthologous to human SFMBT2 (Scm like with four mbt domains 2). [provided by Alliance of Genome Resources, Apr 2022]